Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06588426 · ClinicalTrials.gov registry record
Clinical Readiness Skin Punch Biopsy Sample Collections
A clinical trial of Congenital Heart Defect and Congenital Heart Disease (CHD), sponsored by HeartWorks.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06588426: Recruiting study of Congenital Heart Defect and Congenital Heart Disease (CHD), sponsored by HeartWorks.
NCT06588426 is a study of Congenital Heart Defect and Congenital Heart Disease (CHD) that is actively recruiting participants, run by HeartWorks. The registered enrollment target is 100 participants, above the 86-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06588426, a study of Congenital Heart Defect and Congenital Heart Disease (CHD), is actively recruiting participants, sponsored by HeartWorks.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical readiness skin punch biopsy sample collection study. This will allow to reduce manufacturing time when patients are identified as eligible to receive product under separate interventional treatment protocol.
Primary Outcome
Outcome measured will be the manufacture of iPSC that meets pre-determined acceptance criteria.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2027-07 |
What NCT06588426 shows while recruiting
NCT06588426 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 86-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (16% higher).
The record links to 2 conditions, with Congenital Heart Defect appearing as the primary indexed condition, and to 0 interventions.
NCT06588426 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06588426 about?
NCT06588426 is a clinical study titled "Clinical Readiness Skin Punch Biopsy Sample Collections". This is a clinical readiness skin punch biopsy sample collection study. This will allow to reduce manufacturing time when patients are identified as eligible to receive product under separate interventional treatment protocol.
What is the current status of trial NCT06588426?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-09-13. Estimated completion is 2027-07.
What conditions does trial NCT06588426 study?
This clinical trial studies the following conditions: Congenital Heart Defect, Congenital Heart Disease (CHD).
Who is sponsoring clinical trial NCT06588426?
This trial is sponsored by HeartWorks, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06588426 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Defect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
RECRUITING · NA
-
Peer Coaching Intervention in Young Adults With Congenital Heart Disease
ACTIVE NOT RECRUITING · NA
-
Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making
ACTIVE NOT RECRUITING · NA
-
XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI